These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Antiretroviral treatments to reduce mother-to-child transmission of HIV. Peiperl L HIV Clin Trials; 2001; 2(1):46-55. PubMed ID: 11590514 [No Abstract] [Full Text] [Related]
23. Reduction of materno-fetal transmission of HIV by improved delivery techniques combined with nevirapine treatment in women attending two family planning clinics in Yaounde, Cameroon. Mbu RE; Mbopi-Keou FX; Alemnji G; Nkengasong JN; Meli C; Eteki N; Nana PN; Ako SN; Tonye RN; Leke RJ Int J STD AIDS; 2004 Dec; 15(12):848-9. PubMed ID: 15601503 [No Abstract] [Full Text] [Related]
24. Report from the 16th Conference on Retroviruses and Opportunistic Infections. Lopinavir/r is superior to nevirapine in women who previously received single-dose nevirapine. Feinberg J J Watch AIDS Clin Care; 2009 Apr; 21(4):33. PubMed ID: 19544617 [No Abstract] [Full Text] [Related]
25. Evidence behind the WHO guidelines: hospital care for children: what antiretroviral agents and regimens are effective in the prevention of mother-to-child transmission of HIV? Nightingale S; Dabis F J Trop Pediatr; 2006 Aug; 52(4):235-8. PubMed ID: 16877674 [No Abstract] [Full Text] [Related]
26. Management of human immunodeficiency virus infection in pregnancy. Watts DH N Engl J Med; 2002 Jun; 346(24):1879-91. PubMed ID: 12063373 [No Abstract] [Full Text] [Related]
27. Reports on nevirapine threaten public health. Lane HC; Folkers GK; Fauci AS Nat Med; 2005 Mar; 11(3):245. PubMed ID: 15746930 [No Abstract] [Full Text] [Related]
28. Dual therapy with lamivudine + protease inhibitor during pregnancy for prevention of mother-to-child transmission of HIV-1. Gliga SS; Clavel CO; Alix AF; Dommergues M; Quetin F; Marcelin AG; Schneider L; Stitou H; Calin R; Caby F; Valantin MA; Katlama C; Tubiana R J Acquir Immune Defic Syndr; 2013 Aug; 63(5):e159-63. PubMed ID: 24135778 [No Abstract] [Full Text] [Related]
32. Plasma lopinavir trough levels in a group of pregnant women on lopinavir, ritonavir, zidovudine, and lamivudine. Manavi K; McDonald A; Al-Sharqui A AIDS; 2007 Mar; 21(5):643-5. PubMed ID: 17314527 [TBL] [Abstract][Full Text] [Related]
33. Antiretroviral therapy in HIV-infected pregnant women and their infants: current interventions and challenges. Shannon M J Perinat Neonatal Nurs; 2002 Sep; 16(2):1-25. PubMed ID: 12233942 [TBL] [Abstract][Full Text] [Related]
34. Let nevirapine do what it does best. Huff B GMHC Treat Issues; 2002 Mar; 16(3):10-1. PubMed ID: 12004796 [No Abstract] [Full Text] [Related]
35. AIDS research. IOM panel clears HIV prevention study. Couzin J Science; 2005 Apr; 308(5720):334. PubMed ID: 15831722 [No Abstract] [Full Text] [Related]
36. Public Health Service Task Force recommendations for the use of antiretroviral drugs in pregnant women infected with HIV-1 for maternal health and for reducing perinatal HIV-1 transmission in the United States. Centers for Disease Control and Prevention. MMWR Recomm Rep; 1998 Jan; 47(RR-2):1-30. PubMed ID: 9461044 [TBL] [Abstract][Full Text] [Related]
38. The controversies of nevirapine for preventing mother-to-child HIV transmission. Smith DM AIDS; 2006 Jan; 20(2):281-3. PubMed ID: 16511423 [No Abstract] [Full Text] [Related]
39. Thai study success affects ongoing placebo trials. AIDS Alert; 1998 Apr; 13(4):42-3. PubMed ID: 11365141 [TBL] [Abstract][Full Text] [Related]
40. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection. Brocklehurst P; Volmink J Cochrane Database Syst Rev; 2002; (2):CD003510. PubMed ID: 12076484 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]